Portfolio

Quotient [ENG]

Test for diagnosis and treatment of diabetes

Quotient, a company founded in 2002 as a spin off of Chelsea Instruments Ltd., has developed, produced and marketed the Quo-Test, an apparatus for measuring the concentration of glycated hemoglobin, a parameter of great importance in keeping periodically monitored the state of compensation of diabetic patients (diabetes is the 4th / 5th cause of death in developed countries and affects 250 million people).

 

Acquired in 2010 by:

 

Champion

[Scheda startup - Blocco Champions] Lorem ipsum